Radiation‐induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management
MS Chambers, AS Garden, MS Kies… - Head & Neck: Journal …, 2004 - Wiley Online Library
Background. Xerostomia is a common, debilitating complication of radiation therapy (RT) for
head and neck cancer. This article reviews the pathogenesis of radiation‐induced …
head and neck cancer. This article reviews the pathogenesis of radiation‐induced …
Measuring head and neck cancer symptom burden: the development and validation of the MD Anderson symptom inventory, head and neck module
…, RS Weber, JS Lewin, AS Garden… - Head & Neck …, 2007 - Wiley Online Library
Background. The aim of this study was to develop and validate a symptom inventory for patients
with head and neck cancer and to assess the occurrence and severity of symptoms, the …
with head and neck cancer and to assess the occurrence and severity of symptoms, the …
Intensity modulated proton therapy (IMPT)–The future of IMRT for head and neck cancer
AC Moreno, SJ Frank, AS Garden, DI Rosenthal… - Oral oncology, 2019 - Elsevier
Radiation therapy plays an integral role in the management of head and neck cancers (HNCs).
While most HNC patients have historically been treated with photon-based radiation …
While most HNC patients have historically been treated with photon-based radiation …
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard …
…, CU Jones, SA Spencer, TL Phillips, AS Garden… - International Journal of …, 2000 - Elsevier
Purpose: The optimal fractionation schedule for radiotherapy of head and neck cancer has
been controversial. The objective of this randomized trial was to test the efficacy of …
been controversial. The objective of this randomized trial was to test the efficacy of …
[HTML][HTML] Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis
…, J Moughan, A Trotti, AS Garden… - Journal of Clinical …, 2008 - ncbi.nlm.nih.gov
Purpose Concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head
and neck (SCCHN) increases both local tumor control and toxicity. This study evaluates …
and neck (SCCHN) increases both local tumor control and toxicity. This study evaluates …
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator …
JL Barker Jr, AS Garden, KK Ang, JC O'Daniel… - International Journal of …, 2004 - Elsevier
PURPOSE: Many patients receiving fractionated radiotherapy (RT) for head-and-neck cancer
have marked anatomic changes during their course of treatment, including shrinking of the …
have marked anatomic changes during their course of treatment, including shrinking of the …
Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy
…, J O'Daniel, R Mohan, AS Garden… - Physics in Medicine …, 2005 - iopscience.iop.org
A greyscale-based fully automatic deformable image registration algorithm, originally
known as the'demons' algorithm, was implemented for CT image-guided radiotherapy. We …
known as the'demons' algorithm, was implemented for CT image-guided radiotherapy. We …
[HTML][HTML] Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
…, A Trotti, JJ Beitler, AS Garden… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Combining cisplatin or cetuximab with radiation improves overall survival (OS) of
patients with stage III or IV head and neck carcinoma (HNC). Cetuximab plus platinum …
patients with stage III or IV head and neck carcinoma (HNC). Cetuximab plus platinum …
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for …
Background Human papillomavirus-related (HPV+) oropharyngeal cancer is a rapidly emerging
disease with generally good prognosis. Many prognostic algorithms for oropharyngeal …
disease with generally good prognosis. Many prognostic algorithms for oropharyngeal …
[HTML][HTML] Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225
… Provision of study materials or patients: Nancy Lee, Adam S. Garden, Walter Bosch,
William H. Morrison, Jeanne Quivey, Wade Thorstad, Christopher Jones, K. Kian Ang …
William H. Morrison, Jeanne Quivey, Wade Thorstad, Christopher Jones, K. Kian Ang …
